# US 2019/0376961 A1 · Method for Measuring Fibroblast Growth Factor-23 and Reagent Therefor

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0376961 A1
- Document ID: US20190376961A1
- Status: Published application
- Kind: A1
- Application number: 16/549,387
- Filed: 2019-08-23
- Published: 2019-12-12
- Earliest claimed: 2010-08-31
- Assignees: Kyowa Medex Co., Ltd.
- Applicants: Kyowa Medex Co., Ltd.
- Inventors: Koji Uzawa; Emiko Suzuki; Kazuyuki Ikeda; Kazuki Morita
- Web page: https://patentgrep.com/patent/US20190376961A1

## CPC

- G01N 33/54333: {Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction}
- G01N 33/538: by sorbent column, particles or resin strip {, i.e. sorbent materials}
- G01N 33/54326: {Magnetic particles}
- G01N 33/74: involving hormones {or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors}
- G01N 2333/50: Fibroblast growth factors [FGF]
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A method for measuring fibroblast growth factor-23 (FGF-23) in a sample, which comprise the following steps: (1) reacting, in an aqueous medium, FGF-23 in a sample with magnetic particles, a first antibody or a fragment thereof which binds to FGF-23, and a second antibody or a fragment thereof which binds to FGF-23, to form on the magnetic particles an immunocomplex comprising the first antibody or a fragment thereof which binds to FGF-23. FGF-23, and the second antibody or a fragment thereof which binds to FGF-23; (2) collecting the magnetic particles in the reaction mixture after step (1) by magnetic force, and separating the magnetic particles collected by magnetic force from the other components: and (3) measuring the immunocomplex on the magnetic particles separated in step (2). The present invention provides a method for measuring FGF-23 in a sample, which have a high sensitivity and have a wide measurement range.

## Claims

### Claim 1

A method for measuring fibroblast growth factor-23 (hereinafter indicated as FGF-23) in a sample, wherein the method comprises the steps of:
(1) reacting, in an aqueous medium, FGF-23 in a sample with a magnetic particle, a first antibody or a fragment thereof which binds to FGF-23, and a second antibody or a fragment thereof which binds to FGF-23, to form on the magnetic particle an immunocomplex comprising the first antibody or a fragment thereof which binds to FGF-23, FGF-23, and the second antibody or a fragment thereof which binds to FGF-23;
(2) collecting the magnetic particle in the reaction mixture after step (1) by magnetic force, and separating the magnetic particle collected by magnetic force from the other components; and
(3) measuring the immunocomplex on the magnetic particle separated in step (2).

### Claim 2 (depends on 1)

The method of claim 1, wherein the second antibody is a labeled antibody.

### Claim 3 (depends on 2)

The method of claim 2, wherein the labeled antibody is an alkaline phosphatase-labeled antibody.

### Claim 4 (depends on 1)

The method of claim 1, wherein measurement of the immunocomplex on the magnetic particle in step (3) is carried out by measurement of chemiluminescence.

### Claim 5 (depends on 1)

The method of claim 1, wherein the sample is serum or plasma.

### Claim 6

A reagent for measuring FGF-23 in a sample, which comprises a magnetic particle, a first antibody or a fragment there of which binds to FGF-23, and a second antibody or a fragment thereof which binds to FGF-23.

### Claim 7 (depends on 6)

The reagent of claim 6, wherein the second antibody is a labeled antibody.

### Claim 8 (depends on 7)

The reagent of claim 7, wherein the labeled antibody is an alkaline phosphatase-labeled antibody.

### Claim 9 (depends on 6)

The reagent of claim 6, which further comprises a reagent for measuring chemiluminescence.

### Claim 10 (depends on 6)

The reagent of claim 6, wherein the sample is serum or plasma.
